Sequence Similarity Clusters for the Entities in PDB 3V6F

Entity #1 | Chains: A,C,E,H
Fab e6 Heavy Chain protein, length: 224 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 14047
95 % 1 2 14243 Flexibility: Low
Max RMSD: 1.7, Avg RMSD: 1.2
PDBFlex
90 % 1 2 13974
70 % 1175 2619 2
50 % 2425 5401 1
40 % 2776 6098 1
30 % 3355 7565 1
Entity #2 | Chains: B,D,F,L
Fab e6 Light Chain protein, length: 219 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 15627
95 % 2 3 10798 Flexibility: Low
Max RMSD: 2.2, Avg RMSD: 1.1
PDBFlex
90 % 45 91 281
70 % 1184 2660 1
50 % 2426 5401 1
40 % 2777 6098 1
30 % 3356 7565 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 5IVN 1 A BC2-nanobody 30538
2 5E7B 1 A nanobody nano-L06 9838
3 2P45 2 B ANTIBODY CAB-RN05 9838
4 2X1Q 1 A, B GELSOLIN NANOBODY 9844
5 5U64 1 B VHH-28 9838
6 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
7 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
8 4B41 1 A, B ANTIBODY G7 9844
9 4NZU 1 L 13PL heavy chain Fab 9606
10 4NZU 2 H 13PL light chain Fab 9606
11 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
12 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
13 5IMM 1 B Nanobody 9835
14 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
15 5NLU 1 A single domain llama antibody Nb36 9844
16 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
17 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
18 1MEX 1 L Fab 29G12 light chain 10090
19 1MEX 2 H Fab 29G12 heavy chain 10090
20 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
21 5IMK 1 B Nanobody 9835
22 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
23 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
24 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
25 4BUH 1 A, B CLONE M0418 SCFV 9606
26 4B50 1 A 2H10 LLAMA VHH 9844
27 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
28 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
29 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
30 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
31 6DBA 1 A, B nanobody VHH R303 9838
32 5YD4 1 A, C, E, G scFv 4B08 10090
33 5YD3 1 A, C, E, G scFv 4B08 10090
34 2XT1 2 B CAMELID VHH 9 30538
35 5UD9 1 H Fab heavy chain 9606
36 5UD9 2 L Light chain 9606
37 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
38 4P48 1 A Antibody scFv 180 9031
39 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
40 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
41 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
42 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
43 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
44 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
45 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
46 5J1S 3 C VHH domain BS-2 30538
47 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
48 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
49 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
50 5J1T 3 C VHH domain BS-2 30538
51 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
52 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
53 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
54 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
55 4XCF 1 L 4E10 Fab light chain 9606
56 4XCF 2 H 4E10 Fab heavy chain 9606
57 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
58 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
59 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
60 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
61 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
62 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
63 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
64 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
65 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
66 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
67 5X08 1 H Fab 4E10 Heavy chain 9606
68 5X08 2 L Fab 4E10 Light chain 9606
69 2X1O 1 A, B GELSOLIN NANOBODY 9844
70 4QGY 1 A, B nanobody n25, VH domain 9844
71 5C2B 1 H scFv 3B4 heavy chain 9606
72 4XAW 1 L 4E10 Fab light chain 9606
73 4XAW 2 H 4E10 Fab heavy chain 9606
74 5VNV 1 A Nb.b201 32630
75 4P49 1 A Antibody scFv B8 9031
76 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
77 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
78 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
79 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
80 5DXW 1 A PD-L1 nanobody 10090
81 5UCB 1 H Fab Heavy Chain 9606
82 5UCB 2 L Fab Light Chain 9606
83 2VXV 1 H HUMAN IGG ABT-325 9606
84 2VXV 2 L HUMAN IGG ABT-325 9606
85 4N9O 2 B Nanobody Nb484 Nb484 9844
86 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
87 4GXV 1 H, I Antibody 1F1, heavy chain 9606
88 4GXV 2 L, M Antibody 1F1, light chain 9606
89 2VXT 1 H MURINE IGG 125-2H 10090
90 2VXT 3 L MURINE IGG 125-2H 10090
91 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
92 1T2J 1 A M12-Variable Heavy domain 9606
93 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
94 6DBF 2 B InlB specific VHH R303 9838
95 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
96 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
97 6DBG 2 C, D VHH R303 9838
98 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
99 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
100 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
101 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
102 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
103 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
104 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
105 5W24 1 L 5C4 Fab Light Chain 10090
106 5W24 2 H 5C4 Fab Heavy Chain 10090
107 4HPY 1 H CH59 Fab heavy chain 9606
108 4HPY 2 L CH59 Fab light chain 9606
109 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
110 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
111 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
112 5VM6 1 A single domain camelid nanobody VHH T10 9844
113 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
114 4JG1 1 L Fab light chain 9606
115 4JG1 2 H Fab heavy chain 9606
116 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
117 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
118 4KML 2 B Nanobody 9844
119 5VF2 1 A scFv 2D10 10090
120 5I8C 1 A VRC34.01 Fab heavy chain 9606
121 5I8C 2 B VRC34.01 Fab light chain 9606
122 4O5L 1 L Fab F045-092 light chain 9606
123 4O5L 2 H Fab F045-092 heavy chain 9606
124 5MYX 1 A, C Fab c#24 light chain 10090
125 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
126 4Z9K 2 B VHH2(F5) antibody 30538
127 3IFL 1 L 12A11 FAB antibody light chain 10090
128 3IFL 2 H 12A11 FAB antibody heavy chain 10090
129 5WK2 1 L M116 LIGHT CHAIN 9606
130 5WK2 2 H M116 HEAVY CHAIN FD 9606
131 3PP4 1 H GA101 Fab heavy chain 10090
132 3PP4 2 L GA101 Fab light chain 10090
133 3KDM 1 A, L Immunoglobulin light chain 9606
134 3KDM 2 B, H Immunoglobulin heavy chain 9606
135 5NIV 1 A Light chain of 5D3 Fab 10090
136 5NIV 2 B Heavy chain of 5D3 Fab 10090
137 5N4J 1 L LIGHT CHAIN 9606
138 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
139 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
140 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
141 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
142 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
143 5X4G 1 A 6H8 Fab heavy chain 10090
144 5X4G 2 B 6H8 Fab light chain 10090
145 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
146 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
147 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
148 4PTU 1 A Antibody pn132p2C05, light chain 9606
149 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
150 4TPR 1 L If kappa light chain 10090
151 4TPR 2 H Fab heavy chain 10090
152 5LMW 1 A Nanobody 9844
153 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
154 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
155 3IFN 1 H 12A11 FAB antibody heavy chain 10090
156 3IFN 2 L 12A11 FAB antibody light chain 10090
157 5U3P 1 H DH511.4 Fab Heavy Chain 9606
158 5U3P 2 L DH511.4 Fab Light Chain 9606
159 6BLA 1 H AMM01 Fab Heavy chain 9606
160 6BLA 2 L AMM01 Fab Light chain 9606
161 5NM0 1 A, B, C, D Nb36 9844
162 4TOY 1 H 35O22 Fab Heavy chain 9606
163 4TOY 2 L 35O22 Fab Light chain 9606
164 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
165 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
166 3NPS 2 B S4 FAB HEAVY CHAIN 9606
167 3NPS 3 C S4 FAB LIGHT CHAIN 9606
168 5I4F 1 A scFv 2D10 10090
169 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
170 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
171 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
172 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
173 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
174 5WN9 1 H scFv 2D10 9606
175 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
176 4XC3 1 L 4E10 Fab light chain 9606
177 4XC3 2 H 4E10 Fab heavy chain 9606
178 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
179 4PPT 1 A Engineered single domain VHH antibody 9844
180 3R0M 1 A, B Llama VHH A12 9844
181 4M5Y 1 H, I Fab 5J8 heavy chain 9606
182 4M5Y 2 L, M Fab 5J8 light chain 9606
183 4TQE 1 L If kappa light chain 10090
184 4TQE 2 H Fab heavy chain 10090
185 3ZKQ 2 D XA4813 9844
186 5YY4 1 A scFv 4B08 10090
187 4I13 2 B Protein ca1697 (nanobody) 9844
188 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
189 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
190 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
191 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
192 5C2U 1 B Nanobody Nanobody 9838
193 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
194 5VSI 2 L CH1/Ckappa Fab light chain 9606
195 1XFP 1 A heavy chain antibody VHH domain 9838
196 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
197 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
198 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
199 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
200 5JXA 1 H VRC03 Heavy chain 9606
201 5JXA 2 L VRC03 Light chain 9606
202 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
203 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
204 4POY 1 A VHH-metal 9844
205 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
206 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
207 5NLW 1 A nanobody Nb36 9844
208 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
209 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
210 3NTC 1 L Fab light chain 10090
211 3NTC 2 H Fab heavy chain 10090
212 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
213 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
214 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
215 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
216 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
217 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
218 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
219 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
220 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
221 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
222 6BE3 1 H Fab (F598) Heavy Chain 9606
223 6BE3 2 L Fab (F598) Light Chain 9606
224 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
225 3G9A 2 B Minimizer 9838
226 4NWU 1 H APE1551 Ab Fab heavy chain 9606
227 4NWU 2 L APE1551 Ab Fab light chain 9606
228 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
229 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
230 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
231 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
232 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
233 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
234 5EWI 1 H VRC38.01 Heavy Chain 9606
235 5EWI 2 L VRC38.01 Light Chain 9606
236 5E2W 1 L AT8 LIGHT CHAIN 10090
237 5E2W 2 H AT8 HEAVY CHAIN 10090
238 5MYK 1 A Fab c#17 light chain 10090
239 5MYK 2 B Fab c#17 heavy chain 10090
240 4NZR 1 H PGT135 heavy chain Fab 9606
241 4NZR 2 L PGT135 light chain Fab 9606
242 5MYO 1 A, C Fab c#6 light chain 10090
243 5MYO 2 B, D Fab c#6 heavy chain 10090
244 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
245 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
246 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
247 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
248 5UEL 1 H 354NC102 Fab Heavy Chain 9606
249 5UEL 2 L 354NC102 Fab Light Chain 9606
250 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
251 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
252 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
253 2P43 2 B ANTIBODY CAB-RN05 9838
254 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
255 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
256 5E2V 1 L AT8 LIGHT CHAIN 10090
257 5E2V 2 H AT8 HEAVY CHAIN 10090
258 4KRN 1 A Nanobody/VHH domain EgA1 9844
259 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
260 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
261 4GFT 2 B Nanobody 9844
262 4TVS 2 a, b VHH Domain BS-1 30538
263 4W6Y 2 B Nanobody NbFedF9 9844
264 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
265 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
266 6EZW 1 B VHH antibody BCD090-M2 9844
267 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
268 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
269 5JUE 1 L light chain of UIC2 Fab 10090
270 5JUE 2 H heavy chain of UIC2 Fab 10090
271 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
272 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
273 1UAC 2 H Ig VH,anti-lysozyme 10090
274 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
275 5JR1 1 H 10E8 heavy chain 9606
276 5JR1 2 L 10E8 mature light chain 9606
277 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
278 6CA7 1 L PCT64_13C light chain 9606
279 6CA7 2 H PCT64_13C heavy chain 9606
280 5VF6 1 A single chain variable fragment 9031
281 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
282 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
283 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
284 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
285 5OB5 2 H fAb Heavy chain 9606
286 5OB5 3 L fAb Light chain 9606
287 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
288 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
289 5I66 1 A 8B6 antibody, heavy chain 10090
290 5I66 2 B 8B6 antibody, light chain 10090
291 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
292 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
293 6BZY 1 H 22D11 Heavy Chain 10090
294 6BZY 2 L 22D11 Light Chain 10090
295 3QQ9 1 C, L 101F LIGHT CHAIN 10090
296 3QQ9 2 D, H 101F HEAVY CHAIN 10090
297 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
298 5TKK 3 L mouse antibody vFP5.01 light chain 10090
299 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
300 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
301 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
302 5W6C 1 H UCA Fab heavy chain 9606
303 5W6C 2 L UCA Fab light chain 9606
304 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
305 5I1K 1 L FAB LIGHT CHAIN 9606
306 5I1K 2 H FAB HEAVY CHAIN 9606
307 3OZ9 1 L Fab NC-1 kappa light chain 10090
308 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
309 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
310 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
311 5V7U 1 L CBTAU-22.1 Fab light chain 9606
312 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
313 5UEA 1 A, H Fab Heavy Chain 9606
314 5UEA 3 B, L Fab Light Chain 9606
315 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
316 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
317 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
318 3G5Y 1 A 175 light chain 10090
319 3G5Y 2 B 175 heavy chain 10090
320 5O02 2 C Nanobody (VHH) Nano-4 30538
321 5NMV 1 L Fab light chain 10088
322 5NMV 2 H Fab heavy chain 10088
323 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
324 4N8C 2 L, M Light chain of monoclonal antibody 10090
325 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
326 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
327 4HGW 1 A Antibody Fab fragment, light chain 10090
328 4HGW 2 B Antibody Fab fragment, heavy chain 10090
329 1NLB 1 L antibody 19D9D6 light chain 10090
330 1NLB 2 H antibody 19D9D6 heavy chain 10090
331 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
332 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
333 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
334 3VFG 1 L 3F8 Light Chain 10090
335 3VFG 2 H 3F8 Heavy Chain 10090
336 4X7F 2 C, D Nano-25 Nanobody 30538
337 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
338 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
339 3QRG 1 L Fab light chain 9606
340 3QRG 2 H Fab heavy chain Fd fragment 9606
341 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
342 5M6A 1 A, B, C, D Bence-Jones light chain 9606
343 4LLY 2 B, D light chain Clambda 9606
344 4LGR 2 B Camelid nanobody (VHH3) 30538
345 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
346 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
347 5EZI 1 H Fab c12 heavy chain 9606
348 5EZI 2 L Fab c12 Light chain 9606
349 4K23 1 H anti-uPAR antibody, heavy chain 10090
350 4K23 2 L anti-uPAR antibody, light chain 10090
351 5J57 2 B VHH single chain antibody V5E1 30538
352 3NCJ 1 L Fab15 Mut8 light chain 9606
353 3NCJ 2 H Fab15 Mut8 heavy chain 9606
354 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
355 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
356 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
357 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
358 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
359 5W05 1 L M59 FAB LIGHT CHAIN 10090
360 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
361 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
362 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
363 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
364 5OMM 2 C Nanobody (VHH) Nano-14 30538
365 5E03 1 A mouse CTLA-4 nanobody 10090
366 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
367 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
368 4M61 1 A, C Fab A52 light chain 10090
369 4M61 2 B, D Fab A52 heavy chain 10090
370 5YE3 1 B 2A7D9 VH CH1 chain 10090
371 5YE3 2 A 2A7D9 L chain 10090
372 5LZ0 1 A, B PorM nanobody 9844
373 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
374 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
375 1UM5 1 L Antibody 21H3 L chain 10090
376 1UM5 2 H Antibody 21H3 H chain 10090
377 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
378 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
379 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
380 4NWT 1 L APE1531 Ab Fab light chain 9606
381 4NWT 2 H APE1531 Ab Fab heavy chain 9606
382 6DBE 1 A, B nanobody VHH R303 9844
383 3WHX 1 A mAb Fab H fragment 10090
384 3WHX 2 B mAb Fab L fragment 10090
385 3NA9 1 L Fab15 light chain 9606
386 3NA9 2 H Fab15 heavy chain 9606
387 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
388 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
389 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
390 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
391 4LRI 1 A, B MSL-109 Light Chain 9606
392 4LRI 2 C, P MSL-109 Heavy Chain 9606
393 2XXC 1 B CAMELID VHH 9 30538
394 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
395 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
396 4JN2 1 A, L anti dabigatran Fab 10090
397 4JN2 2 B, H anti dabigatran Fab 10090
398 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
399 4XBE 2 H 4E10 Fab heavy chain 9606
400 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
401 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
402 6BE2 1 H Fab (F598) Heavy Chain 9606
403 6BE2 2 L Fab (F598) Light Chain 9606
404 3QYC 1 A, B VH domain of IgG molecule 9606
405 4JFZ 1 L Fab light chain 9606
406 4JFZ 2 H Fab heavy chain 9606
407 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
408 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
409 5VAK 2 B Nb914 Nanobody 9844
410 3WIF 1 A mAb Fab H fragment 10090
411 3WIF 2 B mAb Fab L fragment 10090
412 5U6A 1 A Light Chain 9606
413 5U6A 2 B Heavy Chain 9606
414 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
415 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
416 3MBX 1 L X836 LIGHT CHAIN 10090
417 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
418 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
419 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
420 2XXM 2 B CAMELID VHH 9 30538
421 6APC 1 H Epididymis luminal protein 214 9606
422 6APC 2 L IGL@ protein 9606
423 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
424 4HHA 1 A Fab KE5 Fab fragment KE5 9606
425 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
426 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
427 4RGO 2 H 14G8 heavy chain Fab 10090
428 4RGO 3 L 14G8 light chain Fab 10090
429 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
430 5GRY 1 A, G diabody 9606
431 5UEK 2 H Fab 12E Heavy Chain 9606
432 5UEK 3 L Fab 12E Light Chain 9606
433 3NAA 1 L Fab15 Mut5 light chain 9606
434 3NAA 2 H Fab15 Mut5 heavy chain 9606
435 6DBD 1 A, B, C, D nanobody VHH R326 9844
436 1Q0X 1 L Fab 9B1, light chain 10090
437 1Q0X 2 H Fab 9B1, heavy chain 10090
438 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
439 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
440 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
441 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
442 5JDS 1 B Nanobody 9835
443 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
444 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
445 5IK3 2 B, D 1E03 Fab fragment light chain 9606
446 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
447 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
448 5XLI 1 a, b FabL 10090
449 5XLI 2 c, d FabH 10090
450 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
451 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
452 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
453 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
454 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
455 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
456 4WUK 1 H CH65 heavy chain 9606
457 4WUK 2 L CH65 light chain 9606
458 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
459 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
460 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
461 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
462 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
463 5JOP 1 D, L Fab 14.22 light chain 10090
464 5JOP 2 E, H Fab14.22 heavy chain 10090
465 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
466 4HPO 1 H CH58 Fab heavy chain 9606
467 4HPO 2 L CH58 Fab light chain 9606
468 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
469 5UKN 2 L DH522UCA Fab fragment light chain 9544
470 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
471 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
472 5L21 2 B VHH-C2 30538
473 5IT2 1 H heavy chain 9606
474 5IT2 2 L light chain 9606
475 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
476 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
477 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
478 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
479 5FWO 1 A NANOBODY 9844
480 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
481 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
482 5MO3 3 L Fab of monoclonal antibody, light chain 10090
483 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
484 5GZ0 1 A, C FM329 light chain 1383439
485 5GZ0 2 B, D FM329 heavy chain 1383439
486 6DW2 1 A 6078 Fab light chain 9606
487 6DW2 2 B 6078 Fab heavy chain 9606
488 3B9V 1 A, B, C, D heavy chain variable domain 9606
489 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
490 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
491 6BQB 1 L MGG4 Fab light chain 9606
492 6BQB 2 H MGG4 Fab heavy chain 9606
493 4PUB 1 H DX-2930 HEAVY CHAIN 9606
494 4PUB 2 L DX-2930 LIGHT CHAIN 9606
495 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
496 6B14 2 L Light chain of Fab BL3-6S97N 10090
497 5N88 1 A, H VH59 antibody 9606
498 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
499 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
500 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
501 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
502 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
503 5GS3 1 A, H diabody protein 9606
504 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
505 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
506 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
507 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
508 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
509 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
510 5VKD 2 H Fab Heavy Chain 9606
511 5VKD 3 L Fab light chain 9606
512 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
513 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
514 5XHG 1 A, C polypeptide(L) 10090
515 5XHG 2 B, D polypeptide(H) 10090
516 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
517 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
518 3UYR 1 H antibody Fab heavy chain 10090
519 3UYR 2 L antibody Fab light chain 10090
520 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
521 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
522 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
523 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
524 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
525 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
526 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
527 3OAZ 2 K, L Fab 2G12, light chain 9606
528 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
529 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
530 1ZAN 1 L Fab AD11 Light Chain 10116
531 1ZAN 2 H Fab AD11 Heavy Chain 10116
532 6CJK 1 A, C Immunoglobulin Fab light chain 9986
533 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
534 4N0Y 1 H IGH526 Heavy Chain 9606
535 4N0Y 2 L IGH526 Light Chain 9606
536 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
537 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
538 5MTH 1 A, H antibody Fab heavy chain 10090
539 5MTH 2 B, L antibody Fab light chain 10090
540 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
541 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
542 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
543 1RZF 1 L Fab E51 light chain 9606
544 1RZF 2 H Fab E51 heavy chain 9606
545 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
546 4KTE 2 L GE148 Light Chain Fab 9544
547 5I8O 1 H HMM5 antibody heavy chain 9606
548 5I8O 2 L HMM5 antibody light chain 9606
549 4OUO 1 A anti Bla g 1 scFv 9031
550 4JG0 1 L Fab light chain 9606
551 4JG0 2 H Fab heavy chain 9606
552 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
553 4YGV 2 B, L aDabi-Fab2a light chain 9606
554 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
555 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
556 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
557 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
558 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
559 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
560 3EO0 1 A, C GC-1008 Fab Light Chain 10090
561 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
562 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
563 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
564 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
565 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
566 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
567 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
568 4POU 2 B VHH Antibody 9844
569 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
570 4FQI 3 H antibody CR9114 heavy chain Fab 9606
571 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
572 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
573 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
574 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
575 4JHA 2 L D25 light chain 9606
576 6B9Z 1 A Trastuzumab Fab light chain 10090
577 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
578 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
579 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
580 4PTT 1 A Antibody pn132p2C05, light chain 9606
581 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
582 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
583 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
584 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
585 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
586 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
587 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
588 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
589 2P42 2 B, D ANTIBODY CAB-RN05 9838
590 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
591 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
592 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
593 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
594 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
595 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
596 4DGV 1 H HCV1 Heavy Chain Fab 9606
597 4DGV 2 L HCV1 Light Chain 9606
598 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
599 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
600 5TH2 1 A, C cetuximab Fab, light chain 10090
601 5TH2 2 B, D cetuximab Fab, heavy chain 10090
602 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
603 5I8K 1 L HHH1 Fab Light chain 9606
604 5I8K 2 H HHH1 Fab Heavy chain 9606
605 4QLR 1 A, B Llama nanobody n02 VH domain 9844
606 5J56 2 B VHH single chain antibody V1C7 30538
607 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
608 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
609 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
610 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
611 1YNL 1 L Ig gamma light chain 10090
612 1YNL 2 H Ig gamma heavy chain 10090
613 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
614 5EPM 2 B, F Antibody Fab fragment light chain 10090
615 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
616 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
617 3UMT 1 A scFv heavy chain and light chain 10090
618 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
619 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
620 4NUJ 1 A PGT152 light chain 9606
621 4NUJ 2 B PGT152 heavy chain 9606
622 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
623 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
624 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
625 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
626 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
627 3U2S 2 B, L PG9 light chain 9606
628 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
629 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
630 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
631 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
632 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
633 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
634 4NUG 1 L PGT151 light chain 9606
635 4NUG 2 H PGT151 heavy chain 9606
636 3IU4 1 H chP3 Fab heavy chain 10090
637 3IU4 2 L chP3 Fab light chain 10090
638 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
639 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
640 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
641 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
642 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
643 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
644 1P7K 1 A, L antibody light chain FAB 10090
645 1P7K 2 B, H antibody heavy chain FAB 10090
646 4NBX 2 B A20.1 VHH 9844
647 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
648 3RVV 2 C 4C1 - light chain 10090
649 3RVV 3 D 4C1 - heavy chain 10090
650 4HEP 2 G vHH17 domain 9844
651 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
652 3P0Y 2 H Fab DL11 heavy chain 9606
653 3P0Y 3 L Fab DL11 light chain 9606
654 4NPY 1 A, L germline PGT121 light chain Fab 9606
655 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
656 6ANA 2 H LL2 Fab Heavy Chain 10090
657 6ANA 3 L LL2 Fab Light Chain 10090
658 5IBU 1 B, L 6652 Light Chain 9606
659 5IBU 2 G, H 6652 Heavy Chain 9606
660 5VPL 2 C 4C1 - LIGHT CHAIN 10090
661 5VPL 3 D 4C1 - HEAVY CHAIN 10090
662 6AOD 1 A FXIa Antibody FAB Light Chain 9606
663 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
664 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
665 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
666 2YPV 2 H FAB 12C1 10090
667 2YPV 3 L FAB 12C1 10090
668 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
669 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
670 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
671 4JY5 1 L PGT122 light chain Fab 9606
672 4JY5 2 H PGT122 heavy chain Fab 9606
673 6ELE 1 A, H fAB heavy chain 9606
674 6ELE 2 B, L fAB light chain 9606
675 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
676 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
677 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
678 6B5R 1 H CIS42 Fab Heavy chain 9606
679 6B5R 2 L CIS42 Fab Light chain 9606
680 5IML 2 B Nanobody 9835
681 3NAC 1 L Fab15 Mut7 light chain 9606
682 3NAC 2 H Fab15 Mut7 heavy chain 9606
683 3A6C 2 H IG VH, anti-lysozyme 10090
684 2DQD 2 H Ig VH,anti-lysozyme 10090
685 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
686 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
687 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
688 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
689 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
690 1Q72 1 L Fab M82G2, Light chain 10090
691 1Q72 2 H Fab M82G2, Heavy chain 10090
692 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
693 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
694 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
695 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
696 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
697 4YHO 1 H aDabi-Fab3 heavy chain 9606
698 4YHO 2 L aDabi-Fab3 light chain 9606
699 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
700 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
701 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
702 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
703 4DGY 1 H HCV1 Heavy Chain Fab 9606
704 4DGY 2 L HCV1 Light Chain 9606
705 3A67 2 H IG VH, anti-lysozyme 10090
706 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
707 5EN2 1 A GD01 heavy chain 10090
708 5EN2 2 B GD01 light chain 10090
709 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
710 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
711 1J1X 2 H Ig VH,anti-lysozyme 10090
712 5M2J 2 D Anti-(ED-B) scFV 9606
713 3MXW 2 L 5E1 light chain 9606
714 3MXW 3 H 5E1 heavy chain 9606
715 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
716 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
717 2DQC 2 H Ig VH,anti-lysozyme 10090
718 1J1O 2 H Ig VH,anti-lysozyme 10090
719 3EO9 1 L Efalizumab Fab fragment, light chain 9606
720 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
721 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
722 4M62 2 H, I GEP2 FV heavy chain 9606
723 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
724 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
725 5IVO 1 A BC2-nanobody 30538
726 1J1P 2 H Ig VH,anti-lysozyme 10090
727 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
728 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
729 4NBZ 2 B, D A26.8 VHH 9844
730 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
731 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
732 5WUV 1 L light chain 9606
733 5WUV 2 H heavy chain 9606
734 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
735 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
736 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
737 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
738 5AYU 2 H Ig VH,anti-lysozyme 10090
739 4JM4 1 H PGT 135 Heavy Chain Fab 9606
740 4JM4 2 L PGT 135 Light Chain Fab 9606
741 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
742 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
743 3A6B 2 H IG VH, anti-lysozyme 10090
744 2DQJ 2 H Ig VH,anti-lysozyme 10090
745 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
746 5YE4 2 B, D 1A9D7 L chain 10090
747 5F21 2 B nanobody MU375 9844
748 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
749 6B0G 1 C 1245 Antibody, Light Chain 9606
750 6B0G 2 D 1245 Antibody, Heavy Chain 9606
751 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
752 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
753 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
754 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
755 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
756 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
757 6D0X 1 A 2140 Antibody, heavy chain 9606
758 6D0X 2 B 1210 Antibody, light chain 9606
759 2P44 2 B ANTIBODY CAB-RN05 9838
760 6BE4 1 H Fab (F598) Heavy Chain 9606
761 6BE4 2 L Fab(F598) Light Chain 9606
762 5TPP 1 L DH270.5 Fab heavy chain 9606
763 5TPP 2 H DH270.5 Fab light chain 9606
764 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
765 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
766 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
767 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
768 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
769 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
770 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
771 5TP3 1 A, B F-VHH-4 9844
772 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
773 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
774 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
775 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
776 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
777 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
778 5TL5 1 L M2177 LIGHT CHAIN 10090
779 5TL5 2 H M2177 HEAVY CHAIN 10090
780 2FX7 1 L Fab 4E10 Light Chain 9606
781 2FX7 2 H Fab 4E10 Heavy Chain 9606
782 5Y9K 1 L belimumab light chain 9606
783 5Y9K 2 H belimumab heavy chain 9606
784 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
785 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
786 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
787 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
788 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
789 4LHJ 2 B Camelid antibody 30538
790 3WFH 1 A mAb Fab H fragment 10090
791 3WFH 2 B mAb Fab L fragment 10090
792 4BEL 2 D, E XA4813 9844
793 5M7Q 1 A, B Nanobody NbD2 9838
794 5H8D 1 A VHH nanobody 9844
795 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
796 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
797 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
798 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
799 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
800 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
801 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
802 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
803 3DUR 2 B, D Ig-like protein 10090
804 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
805 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
806 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
807 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
808 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
809 5HI4 3 D, L CAT-2000 FAB light chain 9606
810 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
811 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
812 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
813 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
814 3RVW 2 C 4C1 - light chain 10090
815 3RVW 3 D 4C1 - heavy chain 10090
816 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
817 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
818 5XKU 2 B HNIgGA6 light chain 9606
819 5XKU 3 C HNIgGA6 heavy chain 9606
820 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
821 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
822 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
823 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
824 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
825 5HI5 3 D, L CAT-2000 light chain 9606
826 5JO5 1 A, C, E, H 10E8 gHV 9606
827 5JO5 2 B, D, F, L 10E8 gLV 9606
828 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
829 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
830 2XV6 2 B, D CAMELID VHH 9 30538
831 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
832 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
833 5CCK 2 L Antibody 3BC315 Fab light chain 9606
834 5VM0 1 A, B Camelid Nanobody VHH T9 9844
835 5I76 1 A, C FM318_light_chain 1383439
836 5I76 2 B, D FM318_heavy_cahin 1383439
837 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
838 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
839 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
840 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
841 5I18 1 L FAB LIGHT CHAIN 9606
842 5I18 2 H FAB HEAVY CHAIN 9606
843 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
844 4JN1 2 L anti-dabigatran Fab1, light chain 10090
845 4ZG1 1 A, B, C, D, E, F NB17 9844
846 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
847 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
848 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
849 4G5Z 2 L canakinumab antibody fragment light chain 9606
850 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
851 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
852 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
853 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
854 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
855 2OK0 2 L Fab ED10 light chain 10090
856 2OK0 3 H Fab ED10 heavy chain 10090
857 6BAN 2 B, D, F, H Variable domain R11 Heavy chain 9606
858 3SOB 1 L antibody light chain 9606
859 3SOB 3 H antibody heavy chain 9606
860 6B5M 1 H CIS43 Fab Heavy chain 9606
861 6B5M 2 L CIS43 Fab Light chain 9606
862 4I1N 2 B Protein ca1697 (nanobody) 9844
863 5AWN 1 H Heavy chain of 3BC176 Fab 9606
864 5AWN 2 L Light chain of 3BC176 Fab 9606
865 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
866 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
867 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
868 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
869 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
870 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
871 5DR5 2 L AbD09097 Fab light chain 9606
872 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
873 2IH3 1 A FAB Heavy Chain 10090
874 2IH3 2 B FAB Light Chain 10090
875 4KQ3 1 L CNTO3186 light chain Fab 9606
876 4KQ3 2 H CNTO3186 heavy chain Fab 9606
877 6F0D 1 A, B VHH antibody BCD090-M2 9844
878 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
879 6AQ7 3 L POM6 FAB light CHAIN 10090
880 4JFX 1 A, L Fab light chain 9606
881 4JFX 2 B, H Fab heavy chain 9606
882 3SGE 1 I, L Light Chain 10090
883 3SGE 2 H, J Heavy Chain 10090
884 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
885 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
886 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
887 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
888 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
889 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
890 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
891 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
892 5FHB 1 H Antibody 100 Fab heavy chain 9606
893 5FHB 2 L Antibody 100 Fab light chain 9606
894 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
895 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
896 1JGU 1 L Antibody Light Chain 10090
897 1JGU 2 H Antibody Heavy Chain 10090
898 4I77 1 H Lebrikizumab heavy chain Fab 9606
899 4I77 2 L Lebrikizumab light chain Fab 9606
900 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
901 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
902 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
903 4O4Y 2 H 2095-2 heavy chain 9986
904 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
905 5OBF 1 H fAb Heavy chain 10090
906 5OBF 2 L fAb Light chain 10090
907 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
908 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
909 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
910 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
911 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
912 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
913 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
914 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
915 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
916 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
917 5MHE 1 L Fab-fragment 10090
918 5MHE 2 H Fab-fragment 10090
919 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
920 4GLR 3 I, K anti-ptau light chain light chain 9031
921 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
922 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
923 4HJG 1 A Trastuzumab light chain 9606
924 4HJG 2 B Trastuzumab heavy chain 9606
925 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
926 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
927 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
928 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
929 5I30 1 L Fab PL-2 light chain 10090
930 5I30 2 H Fab PL-2 heavy chain 10090
931 4W6X 2 B Nanobody NbFedF7 9844
932 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
933 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
934 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
935 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
936 3FN0 1 L Fab Z13e1 light chain 9606
937 3FN0 2 H Fab Z13e1 heavy chain 9606
938 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
939 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
940 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
941 4YHI 2 B, L aDabi-Fab2a light chain